Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis

Completed

Conditions studied: Cystic Fibrosis

In brief

The purpose of this study is to find out whether measurement of body composition has a prognostic value on clinical and overall outcome in pediatric patients with cystic fibrosis.

Key facts

Study ID

NCT01401439

Run by

University of Arkansas

People needed

24

Starts

2012-06-01

Expected to finish

2016-07-01

Last updated by the study team

2016-08-09

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who already have a diagnosis of CF based on universal diagnostic criteria
• Age 7 to 17 years at the time of enrollment
• Under routine medical control at the CF center of Arkansas Children's Hospital(ACH)
• Clinically stable in CF symptoms as determined by investigators

You may not qualify if…

• Unstable current diagnosis of metabolic diseases including liver (cirrhosis) or renal disease
• Failure to give informed consent
• Individuals with pacemakers
• Pregnancy in females of childbearing age. A pregnancy test will be performed on females who are post-menarche before performing a DEXA scan

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.